Ingrezza

Chemical Namevalbenazine
Dosage FormCapsule (oral; 40 mg, 80 mg)
Drug ClassInhibitors
SystemMusculoskeletal
CompanyNeurocrine Biosciences, Inc.
Approval Year2017

Indication

  • To treat tardive dyskinesia in adults.
Last updated on 11/11/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Ingrezza (Valbenazine) Prescribing Information 2017Neurocrine Biosciences, Inc., San Diego, CA